Most pharma brands narrow their search to GMP-certified facilities and stop there. Certification confirms a baseline, but it doesn’t predict whether a plant will hit your delivery windows in month eighteen.

Beyond the certificate

• Backup capacity: Can the site absorb a demand spike, or does one production run block the next client’s slot?

• Serialisation readiness: Track-and-trace requirements vary by destination market — a partner unfamiliar with your target country’s rules creates customs delays later.

• Change-control discipline: How a facility documents and communicates formulation or process changes tells you more about long-term reliability than the audit report.

How we vet manufacturing partners

Every plant in our network is pre-qualified with a secondary backup site, so a single point of failure never becomes a stalled shipment. We also run physical audits year-round and can arrange full virtual walk-throughs on request.

The goal isn’t just finding a plant that can produce your formulation — it’s finding one that can produce it reliably for the next five years.